Abstract. Neurofilaments (NFs), the major intermediate filaments of central nervous system (CNS) and peripheral nervous system (PNS) neurons, are heteropolymers formed from the high (NFH), middle (NFM), and low (NFL) molecular weight NF subunits. To gain insights into how the expression of NF subunit proteins is regulated in vivo, two transgenes harboring coding sequences for human NFM (hNFM) with or without the hNFM multiphosphorylation repeat domain were introduced into mice. Expression of both hNFM constructs was driven by the hNFM promoter and resulted in increased levels of hNFM subunits concomitant with an elevation in the levels of mouse NFL (mNFL) proteins in the CNS of both lines of transgenic mice. The increased levels of mNFL appear specific to NFM because previous studies of transgenic mice overexpressing either NFL or NFH did not result in increased expression of either of the other two NF subunits. Further, levels of the most heavily phosphorylated isoforms of mouse NFH (mNFH) were reduced in the brains of these transgenic mice, and electron microscopic studies showed a higher packing density of NFs in large-diameter CNS axons of transgenic versus wildtype mice. Thus, reduced phosphorylation of the mNFH carboxy terminal domain may be a compensatory response of CNS neurons to the increase in NFs, and reduced negative charges on mNFH sidearms may allow axons to accommodate more NFs by increasing their packing density. Taken together, these studies imply that NFM may play a dominant role in the in vivo regulation of the levels of NFL protein, the stoichiometry of NF subunits, and the phosphorylation state of NFH. NFM and NFH proteins may assume similar functions in regulation of NF packing density in vivo.
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M
AMr~IALtaN neurofilaments (NFs) 1 belong to a large family of intermediate filaments (IFs) that are found in nearly all mammalian cells, and NFs are the major IFs of central nervous system (CNS) and peripheral nervous system (PNS) neurons (Hoffman and Lasek, 1975; Liem et al., 1978; Schlaepfer and Freeman, 1978) . NFs share many structural and biochemical features common to IFs formed from each of the six different classes (i.e., types I-VI) of IF proteins, but NFs possess several unique characteristics (for recent reviews see Nixon, 1993; Fuchs and Weber, 1994) . For example, unlike homopolymeric IFs that are composed of type III IF proteins (e.g., vimentin, peripherin) or the heteropolymeric IFs formed from type I and II keratins, NFs are heteropolymers of three distinct subunit proteins. Because of the unique structure of their genes, the NF triplet proteins are included in a separate class (i.e., type IV) of IF proteins, and they are known as the high (NFH), middle (NFM), and low (NFL) molecular weight NF subunits. Further, both NFM and NFH have extraordinarily long carboxy terminal domains, and their apparent molecular weights (Mr) as determined by SDS-PAGE are much higher than that deduced from their corresponding amino acid or cDNA sequences. This is thought due to the combined effects of a high content of negatively charged Glu residues and repeated motifs containing Lys, Ser, and Pro (KSP motifs) that are referred to as multiphosphorylation repeats (MPR) and are the major sites of phosphorylation in NFH and NFM (Lee et al., 1988a, b) . In addition, the stoichiometry of NFs varies among different CNS and PNS regions, and differs from the stereotyped 1:1 ratio of type I and II IF proteins seen in heteropolymeric keratin IFs (reviewed in Fuchs and Weber, 1994) . For example, more NFH seems required in regions where the axonal diameters are large (e.g., spinal cord and sciatic nerve), compared with regions that primarily contain thin axons (e.g., neocortex). Although NFL is able to self-assemble into long, 10-nanometers-in-diameter filaments in vitro (Geisler and Weber, 1981; Liem and Hutchison, 1982; Mulligan et al., 1991; Balin and Lee, 1991) , recent data suggest that NFL is not competent to form a filamentous network in vivo (Ching and Liem, 1993; Lee et al., 1993) . In contrast to NFL, both NFM and NFH appear to subserve an auxiliary function, and current structural models of NFs, suggest that NFL alone forms the core of individual NFs while NFH and NFM are bound to the surface of these NFs (Liem and Hutchison, 1982; Nixon, 1993) .
Despite the rapid accumulation of biochemical, structural, genetic, and pathological information on NFs and their subunit proteins, the precise function(s) of NFs still remains only partially understood (Nixon, 1993) . For example, NFs have been considered major determinants of the caliber of large-diameter axons (Hoffman et al., 1984 (Hoffman et al., , 1987 , and it is the caliber of axon that controls the conduction velocity of action potentials in large, heavily myelinated axons (Sakaguchi et al., 1993) . NFs also are thought to provide mechanical support for axons and to form a stable structural matrix within axons during neurite outgrowth and elongation to facilitate axonal pathfinding in the developing nervous system (Landmesser and Swain, 1992) . However, recent studies of an NF-deficient mutant quail has again raised questions about the functional importance of NFs in vivo (Yamasaki et al., 1992; Ohara et al., 1993) .
To elucidate the structure and function of NFs as well as other aspects of the biology of NFs in vivo, a number of different transgenic mice have been developed and used as experimental model systems. For example, transgenic mice have been used to identify promoter sequences that direct tissue-or cell-type specific expression of NF proteins (Julien et al., 1987; Lee et al., 1992; Reeben et al., 1993; Elder et al., 1994) , to probe the alternative adenylation of NFL mRNA (Beaudet et al., 1993a) , to dissect out the regulatory sequences that control the levels of NF proteins (Beaudet et al., 1992) , and to establish animal models of human neurodegenerative diseases (C6t6 et al., 1993; Xu et al., 1993; Eyer and Peterson, 1994; Vickers et al., 1994) . To gain insights into the role NFM might play in regulating the level of endogenous mouse NFL (mNFL) and NFH (mNFH), two different lines of transgenic mice that constitutively overexpress human NFM (hNFM) were examined in this study. In contrast to earlier transgenic mice designed to overexpress NFL or NFH, the overexpression of hNFM in both lines of transgenic mice described here induced increased levels of mNFL proteins and diminished the levels of the most heavily phosphorylated isoforms of mNFH. Based on our studies of these transgenic mice, we conclude that NFM may play a dominant role in regulating NFL level and the phosphorylation state of NFH in vivo.
Materials and Methods

Transgenic Mice
The two new lines of hNFM transgenic mice studied here were generated as described earlier Elder et al., 1994) . The transgenic mice were identified by Southern blot analysis of tail DNA as described Cole et al., 1994; Elder et al., 1994) . The transgene copy number in each line was also determined by Southern blot analysis of tail DNA digested with BamHI and probed with pNF4 (Myers et al., 1987) , which hybridized with both endogenous and transgenic NFM DNAs. The copy number of the transgenes was estimated by determining the ratio of the transgenic hNFM DNA to the endogenous mNFM DNA.
Quantitative Western Blots
Transgenic and age-matched wild-type mice were sacrificed by carbon dioxide asphyxiation. Different regions of the CNS were dissected out immediately and homogenized in BUST buffer (8 M urea, 0.5% SDS, 2% 13-mercaptoethanol, and 50 mM Tris, pH 7.4) at a ratio of i ml/100 mg wet tissue, according to previously described methods Cole et al., 1994) . The tissue suspensions were sonicated well and centrifuged in a TL-100 ultracentrifuge (Beckman Instruments, Fullerton, CA) at 100,000 g for i h at 25°C, and the protein concentrations in the supernatants were determined. Proteins were separated on 7.5% SDS-PAGE gels, arid different amounts of total protein from different tissues were loaded in each lane of a gel according to the following scheme: neocortex and hippocampus, 40 Ixg; brain stem, 20 ~g; and spinal cord and peripheral nerves, 10 p.g. For quantitative experiments, identical amounts of proteins from transgenic and control samples were loaded in groups of six separate lanes of the same gel. Gels were transferred to nitrocellulose membranes for qualitative and quantitative Western blot studies as described de Waegh et al., 1992; Lee et al., 1992; Bramblett et al., 1993; Cole et al., 1994) . The membranes were blocked for 1 h in TBS, pH 7.6, containing 5% nonfat milk. Primary antibodies specific for each of the NF subunits, some of which recognize NFH or NFM in different states of phosphorylation (see Table I ), were applied to the nitrocellulose membranes overnight. After five washes in GB buffer (50 mM triethanolamine, 100 mM NaCl, 2 mM EDTA, 1 mM sodium azide, 0.1% SDS, and 0.5% Triton X-100, pH 7.5) and a final wash in PTX buffer (10 mM phosphate buffer, pH 7.3, 300 mM NaC1, 2 mM EGTA, 2 mM sodium azide), the membranes were probed with either 10 txCi I125-1abeled goat anti-mouse IgG (ICN Radiochemicals, Irviue, CA) for mouse primary antibodies or 10 ~Ci I125-1abeled Protein A (ICN) for rabbit primary antibodies for 1 h. After 5 washes in GB buffer, the blots were dried and placed on PhosphorImager plates (Molecular Dynamics, Sunnyvale, CA) for 4 h. The plates were then scanned, and the abundance of bound antibody overlying the labeled bands was quantified with ImageQuant software (Molecular Dynamics). 
RNase Protection Assays
Isolation of total cellular RNA from whole-brain and RNase protection assays was performed on 1-mo-old to 3-mo-old trangenic mice and their corresponding wild-type age-matched controls, as previously described , with [a_32p] UTP-labeled probes. The murine NFM and murine [~-actin probes have been described previously . To construct a probe for murine NFL, a cDNA clone containing amino acid 22 to the poly A site cloned as a SmaIfEcoRI in pUC8 (gift of Dr. N. Cowan), was cloned as a SalI/EcoRI fragment into pBluescript II SK+. NFL sequence 3' to the Sacl site at amino acid 415 (Lewis and Cowan, 1986) was removed by digesting with SacI and religating the ends. For use as a probe template, this final plasmid was digested at a KpnI site found at amino acid 368, made blunt ended with T4 DNA polymerase, and a probe was synthesized with T3 RNA polymerase. This probe protected a 140-bp product. A murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA in pBSIIKS (pCCD32) was obtained from Dr. D. Werner (Lu et al., 1990) . After digestion with AvaII, a T7 RNA polymerase-generated probe protected a 240-bp fragment. Each reaction contained 5-p.g brain RNA and 5-1~g tRNA. Quantitation was done by densitometry. To ensure linearity, a set of RNA standards containing 0-10 ~g wild-type brain RNA supplemented with tRNA as needed to give 10 I~g in each sample was run in all experiments. Experimental samples were always run in duplicate. Murine NFL and NFM levels were normalized to the levels of actin or GAPDH expression, respectively.
Immunohistochemistry
The properties of the anti-NF-subunit-specific antibodies used here are summarized in Table I . Tissue fixation by immersion in 70% ethanol/150 mM NaCI, as well as tissue processing and sectioning and the immunohistochemical procedures used here are described in a number of publications (e.g., Lee et al., 1986 Lee et al., , 1987 Trojanowski et al., 1986 Trojanowski et al., , 1989 Schmidt et al., 1987 Schmidt et al., , 1991 . Briefly, the immunohistochemical procedures involved application of the primary anti-NF protein antibody overnight at 4°C, followed by the detection of bound antibody using a peroxidase anti-peroxidase or avidin biotin complex reporter system. To demonstrate quantitative differences in the immunohistochemical-staining intensity obtained with some of these antibodies, 6-~m-thick sections from the same brain levels of transgenic as well as control mice were cut and placed side by side on the same slides for comparative immunohistochemical studies with the same antibody.
Electron Microscopic Studies
Adult transgenic and age-matched control mice were sacrificed by carbon dioxide asphyxiation and perfusion-fLxed through the heart, as described earlier (Trojanowski and Gonatas, 1983; Cole et al., 1994) . After flushing the intravascular compartment with 50 ml of 0.1 M cacodylate buffer pH 7.4, the mice were perfused with 50 ml of fixative (2% paraformaldehyde and 2% glutaraldehyde/0.1 M cacodylate buffer, pH 7.4). The brains were dissected out and immersion-fixed for an additional 24 h. Samples, including the alveus and adjacent hippocampus, from one of the transgenic mouse lines (i.e., the N F M B a m -mice described in Results) and from the wild-type mice were trimmed to I mm 3 under a dissecting microscope; the samples were postfixed in osmium tetroxide for 20 min, dehydrated, and then embedded in Epon-Araldite resin. For morphometric studies of the density of NFs in axons running in the alveus, ultrathin sections through the alveus and adjacent hippocampus were examined under an electron microscope (Hitachi, H-600, Nissei Sangyo, America Ltd., Gaithersburg, MD). 60 axons from the alveus of each animal were photographed at a nominal magnification of x20,000. Axons in the white matter of the alveus cut exactly in cross-section were randomly selected, and all of the NFs in each of these axons were counted using methods similar to those described earlier (Cole et al., 1994) . For quantitation, we arbitrarily classified these axons into the following six size categories: axons with diameters 0.1-0.3, 0.3-0.5, 0.5-0.7, 0.7-0.9, 0.9-1.2, and 1.2-1.5 p,m. We then counted the number of NFs per axon and, for both transgenic and wild-type mice, grouped these data together for axons belonging to each of the size categories.
Statistical Analyses
Statistical analyses of the quantitative immunoblot data and of the morphometric data on the density of NFs were performed using a t test and Microsoft Excel software as described (Cole et al., 1994) .
Results
Production of Transgenic Mice
Three lines of transgenic mice carrying hNFM transgene were generated. The NFM27 line was characterized and reported earlier , and studies of this line are not presented here except to compare the transgene copy number in the NFM27 mice with the other two lines of transgenic mice, because our previous study showed low levels of hNFM protein expression in this line (Fig. 1) 
Distribution of hNFM mRNA in the CNS of Transgenic Mice
Northern blot analysis of different CNS regions was performed to determine the expression levels of the transgenic h N F M B a m -m R N A in the N F M B a m -mice. The expression of the full-length hNFM transgene driven by its own promoter was previously shown to be restricted mainly to neural tissues . Since less NF m R N A transcripts were present in the hippocampus and neocortex than in brain stem and spinal cord, 50 p~g of total RNA from hippocampus and neocortex and 20 p~g of total RNA from brain stem and spinal cord were loaded in each lane. The pNF4 probe detected an m R N A band shorter than mNFM m R N A in all four regions of the CNS of N F M B a m -mice (Fig. 2 A) . The same blots were stripped and reprobed with the BamHI-BamHI D N A fragment that is deleted in the N F M B a m -transgene, and only the endogenous mNFM m R N A was seen in transgenic mice (data not shown), which confirmed that this shorter band was the transgenic h N F M B a m -mRNA.
The ratio of h N F M B a m -mRNA to mNFM m R N A was calculated as described earlier. Quantitative Northern blot analyses demonstrated that the relative expression levels of transgenic m R N A varied among different regions of the CNS (Fig. 2 B) . Hippocampus and neocortex expressed as much hNFM m R N A as mNFM mRNA. However, in brain stem and spinal cord, the transgene transcripts were about half of the endogenous mNFM mRNA. If the amount of RNA loaded for each region is taken into consideration, the absolute amounts of hNFMBam-mRNA transcripts in the brain stem and spinal cord are equal to or greater than those in neocortex and hippocampus. The RNase protection assay of NFM37 mice demonstrated that Each bar represents at least six observations obtained from quantitative Northern blots of 12 age-matched animals. In one blot, each sample was identically loaded into three lanes of a given blot, and the amount of radioactivity in the three lanes from the same sample was averaged and considered as one observation. the hNFM m R N A was expressed at relatively high levels both in brain and spinal cord .
Transgenic hNFM Protein Expression Correlates with hNFM mRNA Levels
Well-characterized monoclonal (mAbs) and polyclonal antibodies (Table I ) specific for NF proteins (including mAbs that distinguish between differentially phosphorylated isoforms of NFH and NFM) were used for immunoblot studies of transgenic and wild-type mice. Quantitative Western blots revealed an h N F M B a m -band in the N F M B a m -mice of ~100 kD, whereas the Mr of hNFM in the NFM37 line was ~170 kD (Fig. 3, A and C) . The large molecular weight difference resulted not only from the deletion of 242 amino acids in h N F M B a m -protein, but also from the inability of the N F M B a m -to be phosphorylated because the major phosphorylation sites are contained within the deleted region. The full-length transgenic hNFM protein had the same Mr as that of native, heavily phosphorylated hNFM protein, and it was recognized by mAb HO14, which binds specifically to heavily phosphorylated hNFM protein (data not shown, but see Lee et al., 1992; Schmidt et al., 1987) . These data suggest that this full-length transgenic hNFM protein was phosphorylated in murine neurons to the same extent as in human neurons of the normal adult CNS.
The ratio of hNFM and h N F M B a m -protein to endogenous mNFM protein was used to estimate the relative abundance of the transgenic protein in the CNS. Neocortex and hippocampus expressed as much h N F M B a mprotein as mNFM, but the brain stem and spinal cord expressed much lower levels of h N F M B a m -protein, that is, ~35% of those for mNFM protein (Fig. 3 B) . Peripheral nerves such as the sciatic and trigeminal nerves also contained relatively lower levels of transgenic h N F M B a mprotein (data not shown). However, when the amount of protein loaded was taken into consideration, the absolute amount of h N F M B a m -protein in brain stem and spinal cord of the N F M B a m -mice was very similar to that seen in the neocortex and hippocampus of these same mice.
The levels of the transgenic h N F M B a m -protein in the four nervous regions correlated with their h N F M B a mmRNA levels. The high levels of hNFM protein observed in all CNS regions tested in line NFM37 (Fig. 3 D) also correlated with a relatively high level of hNFM RNA expression in this line . We have also observed a close relationship between human NFM m R N A and its protein levels in a previously described transgenic line NFM27 . Thus, it seems likely that in all these lines, the level of hNFM protein is controlled primarily at the transcriptional level.
Transgenic hNFMBam-Proteins Are Incorporated into Intermediate Filaments In Vivo
To monitor the copolymerization of h N F M B a m -with other endogenous mouse NF subunits into IFs in vivo, neocortical samples of the N F M B a m -and control mice were extracted with a high-salt buffer containing Triton X-100. This buffer separates unincorporated proteins into the supernatant while retaining the proteins assembled as IFs in the pellets (Fig. 4 A) . Quantitative Western blotting showed that ~90% of h N F M B a m -transgenic protein was retained in the pellets and only 10% was recovered in the soluble fraction. This percentage of soluble h N F M B a m -protein was very close to that of soluble mNFM protein in both the transgenic and wild-type mice (Fig. 4 B) . These results demonstrated that h N F M B a mtransgenic proteins were incorporated into filaments in vivo to the same extent as the endogenous mNFM proteins, regardless of the deleted MPR in the tail domain of the transgenic NFM protein. Furthermore, the transgenic protein did not appear to displace endogenous NF proteins from NFs since the percentage of soluble mNFM, mNFL, and mNFH in the N F M B a m -mice was similar to that in the wild-type mice (Fig. 4, C and D) .
The Expression of hNFM in Transgenic Mice Is Associated with Increased Accumulation of mNFL
Because NFs are obligate heteropolymers of the NF triplet, and these subunits are assembled into NFs with a defined stoichiometry in vivo, we sought to determine the consequences of the expression of the hNFM protein on the relative levels of the endogenous mouse NF subunits in the transgenic mice. Representative immunoblots of the NF proteins from N F M B a m -and NFM37 transgenic mice versus wild-type mice that were used for quantitation are shown in Fig. 5 . Remarkably, quantitative data of these blots demonstrated that mNFL protein increased in the CNS of both lines of transgenic mice relative to those of wild-type mice. In N F M B a m -mice, there was a consistent twofold increase in the relative abundance of mNFL in the neocortex and hippocampus, where the relative levels of transgenic h N F M B a m -proteins were high (Figs. 5 A, and 6, A and C). In contrast, in the spinal cord, where the level of h N F M B a m -proteins was only ~35% of mNFM proteins, the relative abundance of mNFL of these mice was similar to that of the wild-type mice (Fig. 5 B) . However, mNFL was also increased in the brainstem of the N F M B a m -mice (i.e., similar to neocortex and hippocampus), despite the fact that the h N F M B a m -proteins were expressed at a level of only 40% of that of the mNFM protein. Similar studies of the NFM37 transgenic mice revealed a similar increase of mNFL protein in all of the CNS regions where the relative levels of hNFM proteins were high (Figs. 5, C and D, and 6, D and F).
Increased mNFL in Transgenic Mice Is Regulated at the Posttranscriptional Levels
To determine if the increase in mNFL protein in transgenie mice resulted from an increase in mNFL message levels, RNase protection assays were conducted on both Figure 5 . Representative Western blots of 3-too-old NFMBammice versus wild-type mice and NFM37 versus wild-type littermate mice that were used for quantitation. Six identical lanes from either neocortex or spinal cord of transgenic and wildtype mice were loaded in one gel and transferred to nitrocellulose membranes. The blots of NFMBam-versus wild-type mice were cut into three parts. The NFH bands were revealed with the mAb RMO24, which recognized murine heavily phosphorylated NFH (mNFH p3+) epitope; the NFM bands were revealed with the mAb RMO189, which recognized the rod domains of hNFMBam-and mNFM proteins, and the NFL bands were revealed with a polyclonal rabbit anti-NFL antiserum. The blots of NFM37 versus wild-type mice were cut into two parts. The top part was incubated with the antibody mixture of either RMO24 and RMO189 (C) or RMdO9 and RMO189 to reveal the nonphosphorylated NFH isoform (mNFH P-) (D) in neocortex of NFM37 mice. The bottom part was incubated with the polyclonal rabbit anti-NFL antiserum.
Tu et al. Regulation of Neurofilament Protein Expression
N F M B a m -and NFM37 transgenic mice using a murine NFL probe that protected a 140-bp segment of mNFL m R N A (Fig. 7 A) . These studies showed that the levels of mNFL m R N A in both lines of transgenic mice were not elevated compared with age-matched wild-type mice (Table  II) . These data suggest that the induction of mNFL protein in the transgenic mice is regulated by posttranscriptional mechanisms. Further, RNase protection assays of mNFM (Fig. 7 B) showed that the levels of mNFM m R N A in both lines of transgenic mice also remained unchanged when compared with the control mice (Table II) , and this was consistent with the finding that the levels of mNFM protein in the transgenic mice were the same as those in the control mice (Figs. 5 and 6 ).
mNFH Subunits Are Phosphorylated to a Lesser Extent in Transgenic Mice Than in Wild-Type Mice
In view of the shared structural and biochemical properties of mNFH and hNFM that may render similar domains in these NF proteins (e.g., the MPR domains) functionally redundant, we sought to determine if the overexpression of hNFM might influence posttranslational modifications (e.g., phosphorylation) of mNFH that are thought to regulate the dynamic functions of these proteins (de Waegh et al., 1992; Nixon, 1993; Cole et al., 1994) . Using the RMO24 mAb (which recognizes a heavily phosphorylated or mNFHP 3+ epitope) and the mAb RMdO9 (which recognizes a nonphosphorylated or m N F H P -epitope), we noted that the neocortex, hippocampus, and brainstem of the N F M B a m -mice had 20% less mNFH p3+ isoforms than the same regions in the wild-type mice (Fig. 6, A and B) . A similar decrease in the abundance of the highly phosphorylated mNFH p3+ was also observed in the brains of the NF37 transgenic line (Figs. 5, C and D, and 6, D and E). Furthermore, a protein band with a molecular weight similar to that of the m N F H P -isoform was detected in the neocortex (Fig. 5 D) and hippocampus (data not shown) of NFM37 mice by RMdO9 mixed with RMO189, but not by RMO24 mixed with RMO189 (Fig. 5 C) . Since the same band also was detected by RMdO9 alone (data not shown), this band undoubtedly was the poorly phosphorylated m N F H P -protein. Interestingly, we did not see this band in the same brain regions of the N F M B a mmice (data not shown). There was no significant diminution in the levels of the highly phosphorylated NFHP 3+ isoforms in the spinal cord of either the N F M B a m - (Fig.  6, A and B) or the NFM37 mice (Fig. 6, D and E) . Thus, our data suggest that the phosphorylation state of mNFH protein decreased in the telencephalic neurons of both transgenic lines, and that this occurred to a greater extent in the NFM37 mice than in the N F M B a m -mice.
Antibodies to NF Subunits Differentially Stain Axons of Transgenic versus Wild-Type Mice
Immunohistochemistry was used to confirm the Western blot data and to visualize the differential expression of NF proteins in the 1.5-and 3-mo-old transgenic versus the wild-type mice in situ. We focused our observations on the neocortex and hippocampus because these two regions had the highest relative levels of the transgenic hNFM protein. Fig. 8 shows representative data from the N F M B a mmice, which were obtained with three different antibodies to NF subunits, and Table I NFM antibodies (e.g., RMO44) to epitopes that were shared between transgenic and endogenous NFM proteins stained axons in the hippocampus and neocortex of the N F M B a m -mice more strongly than did the wild-type counterparts (compare Fig. 8, B and E) . Further, the staining intensity of axons in the N F M B a m -mice with a rabbit anti-NFL polyclonal antiserum also was stronger than that seen in the wild-type mice (compare Fig. 8, C and F) . However, the three anti-NFH antibodies yielded results that did not differ in the N F M B a m -versus the wild-type mice, and we ascribe this to the fact that the 20% decrease in the levels of the m N F H p3+ isoforms observed by Western blot methods in these transgenic mice was not large enough to be visualized by immunohistochemistry. Notwithstanding, the immunohistochemical studies described here served to confirm and extend the key immunochemical data. Less detailed studies of the 3-mo-old NFM37 mice yielded similar observations (data not shown). Finally, although perikaryal and/or axonal aggregates of NFs have been detected in other lines of NF transgenic mice (C6t6 et al., 1993; Xu et al., 1993; Eyer and Peterson, 1994; Vickers et al., 1994) , none were observed in the transgenic mice studied here or in the 1-yr-old N F M B a m -mice (data not shown). These data suggest that the overexpression of NFM protein in these two lines of transgenic mice is not incompatible with the efficient export of NFs from perikarya into axons and the subsequent orthograde transport of NFs down the axon.
Packing Density of Neurofilaments Is Increased in Axons of Transgenic Mice versus Those of Wild-Type Mice
Electron microscopic studies were performed to compare the packing density of NFs in telencephalic white-matter axons of the transgenic mice versus those of the wild-type mice. To do this, we focused our quantitative studies of axonal NFs on the alveus because this is a reproducibly identifiable white-matter tract of the hippocampus wherein we noted large differences in the intensity of the NF protein immunoreactivity between the N F M B a m -and the wildtype mice. The axons in this area are in the 0.1-1.5 tzm in . Protected fragments were separated as double-stranded RNA on a 6% native polyacrylamide gel. Positions of the actin and mNFL protected fragments are indicated. In B, hybridizations were performed with 40,000 cpm of an mNFM-specific probe and 10,000 cpm of a murine GAPDH probe. Lane order is the same as in (A). Exposures in both A and B were for 18 h.
diameter range, with most in the 0.3-0.8 Ixm size class. For quantitative study, alvear axons were arbitrarily divided into six size categories, with axonal diameters of 0.1-0.3, 0.3-0.5, 0.5-7, 0.7-0.9, 0.9-1.2, and 1.2-1.5 t~m. Fig. 9 shows the representative axons (A) and their NF density distribution histogram (B) from the second size category. These data reveal a shift to the right in the NF packing density for the N F M B a m -mice. The number of NFs in 180 axons of this category from three N F M B a m -mice and 180 axons of the same size class from three wild-type mice were counted, and the results are shown in Table III . The total NF number of the N F M B a m -mice was 8,100 and that of the wild-type mice was 5,580. The average number of NFs per axon was 45 in the N F M B a m -mice and 31 per axon in the wild-type mice (P < 0.01). Thus, the axons had a higher NF packing density in the transgenic versus the wild-type mice; the same trend was also demonstrated in all other axonal categories (Table III) .
D i s c u s s i o n
The studies described here sought to gain insights into the Quantitation of mouse NFL and NFM m R N A in transgenic lines. RNase protections assays were performed as described in experimental procedures and illustrated in Fig. 7 . Two transgenic and two control adult animals (aged 1-3 too) were analyzed from each line. Expression in control animals was set at 100 and values are given with standard deviations. Results are the average of at least six observations on whole-brain RNA in each animal. Values for paired t tests are: NFL in NFM37 vs. control, P = 0.048, and N F M B a m -vs. control, P = 0.059; NFM in NFM37 vs. control, P = 0.013, and N F M B a m -vs. control, P = 0.678.
regulation of NF protein metabolism and the stoichiometry of NF subunits using transgenic technology. We have shown that overexpressing hNFM in the CNS of both types of transgenic mice induces increased levels of mNFL proteins in addition to reducing levels of highly phosphorylated isoforms of mNFH and increasing the packing density of NFs in large-diameter CNS axons. We speculate that these effects are specific to NFM because previous studies of transgenic mice that express NFL or NFH did not evidence similar changes. The observations on the spacing of NFs in CNS axons suggest that neurons try to accommodate increased NFs in their axons by reducing their interfilamentous spaces. The concomitant decrease in mNFH p3+ isoform is compatible with the view that the decrease of phosphorylation state of the carboxy terminal MPR domain of NFH increases the packing density of axonal NFs by reducing the negative charges on NFH sidearms, which limits lateral extension of the tail domain of NFH away from individual NFs de Waegh et al., 1992; Cole et al., 1994; Nixon et al., 1994) . Taken together, the data from these two lines of transgenic mice have two important implications for understanding how the NF network is regulated in neurons, that is, these data suggest that (1) NFM may play a dominant role in the in vivo regulation of NFL levels, the stoichiometry of NF subunits and the phosphorylation state of NFH, and (2) the packing density of NFs in CNS axons is determined by both the NF numbers and the phosphorylation state of NFH. Native NFs have been estimated to assemble at molar ratios for NFH, NFM, and NFL, ranging from 1:2:2 to 1:2:9 depending on the species and neuronal populations investigated (Mori and Kurokawa, 1980; Shecket and Lasek, 1980; Brown et al., 1981; Moon et al., 1981; Chiu and Norton, 1982; Scott et al., 1985) . Although all three NF subunit proteins are competent to self-assemble into long IFs when combined together in vitro Liem and Hutchison, 1982) , NFL forms a filamentous network of IFs in vivo only in the presence of either NFM or NFH (Ching and Liem, 1993; Lee et al., 1993) . Further, an imbalance in the molar ratio of NF proteins has been implicated as a mechanism responsible for certain neurodegenerative conditions such as motor neuron diseases (C6t6 et al., 1993; Xu et al., 1993) . This is consistent with the notion that changes in the molar ratio of NF proteins may alter the transport of NFs down axons, thereby resulting in the accumulation of perikaryal and axonal aggregates of NFs. Thus, disruption of mechanisms that regulate the stoichiometry of the subunit proteins of NFs may impair the function of neurons and lead to lethal consequences.
It is possible that one or more of the NF triplet proteins serve to regulate and maintain the stoichiometry of these subunits in intact NFs. Since transgenic mice that overexpress different NF subunits seem to tolerate a wider range in the levels of NFL compared to NFH and NFM (Monteiro et al., 1990; Cote et al., 1993; Xu et al., 1993; Vickers et al., 1994) , NFL probably is unlikely to regulate the stoichiometry of NF proteins. Further, the delayed appearance of NFH during development suggests that NFH also is unlikely to regulate NF stoichiometry. However, the present studies show that an exogenous hNFM protein becomes incorporated into the cytoskeleton in vivo and reg-ulates the stoichiometry of the endogenous mouse NF proteins.
The ratio of hNFM to mNFM proteins was high in the neocortex and the hippocampus in N F M B a m -mice, but low in the brain stem and the spinal cord. However, the absolute amounts of transgenic hNFM proteins in the latter two regions were equal to or greater than those in the former two regions, which suggests that the transgene was expressed as efficiently in the spinal cord and brainstem as in the neocortex and hippocampus. The detection of relatively low levels of transgenic hNFM in the spinal cord and brain stem may in part reflect the fact that many more en- The mAb RMO44 (which recognizes rod domains of both hNFMBam-and mNFM proteins) stains transgenic tissue more strongly than the wild-type tissue (B and E, respectively) . The induction of mNFL protein in the transgenic NFMBam-mice is evidenced by the stronger staining than in the wild-type mice using the rabbit anti-NFL antibody (C and F, respectively).
dogenous NF proteins are present in these two regions. Quantitative Western and Northern blot data correlated the expression of hNFM protein with the level of hNFM mRNA, which suggested that the expression of the transgene is basically controlled at the transcriptional level and that it is subjected to the same transcriptional regulation in all of the CNS regions. The NFM27 mice not examined in this study expressed relatively low levels of hNFM mRNA, resulting in low expression of hNFM and no evidence of increased levels of NFL induction by Western blot analysis . Although the NFM37 mice expressed higher levels of hNFM proteins in all four CNS regions examined here, the reasons for this are not obvious. However, it is possible that the site of integration of the genomic D N A for hNFM in the NFM37 mice influences the level of expression of this protein in the CNS. Interestingly, we noted a concomitant increase in the levels of mNFL proteins wherever the ratio of hNFM to mNFM was high in both of the transgenic lines. These data suggest that the relative levels of hNFM, rather than the absolute amounts of hNFM, are responsible for inducing the increased expression of mNFL. A similar phenomenon had been observed previously for other IFs in the cultured ceils. For example, the expression of a keratin type II (i.e., K6b) protein was shown to induce the synthesis of a keratin type I protein in 3T3 fibroblasts transfected with a construct encoding the K6 IF protein (Giudice and Fuchs, 1987) . Similarly, when desmin was transfected into T24 ceils, it also induced the synthesis of endogenous vimentin in these cells (Pieper et al., 1992) . The present study is the first to show an increase in one subunit (i.e., NFL) of a heteropolymeric IF by another subunit (i.e., NFM) that normally is found in the same IF in vivo. Because this was seen in two lines of hNFM transgenic mice and correlated well with the expression levels of hNFM protein, it is unlikely these findings reflect effects due to the site of integration of the transgene. Indeed, the increase in mNFL was unique in that there was no change in the levels of mNFM and mNFH proteins; it also appeared to be due specifically to the overexpression of NFM, because transgenic mice that overexpressed NFL or NFH did not induce changes in the levels of the other NF subunits (C6t6 et al., 1993; Xu et al., 1993; Tu and Lee, unpublished) . Thus, we infer that a unique function of NFM protein may be to regulate and maintain the stoichiometry of NF subunits in vivo. This view is also supported by several other lines of evidence. First, in lower animal species such as Myxicola or lamprey, the major NF subunit has characteristics similar to mammalian NFM protein (Chin et al., 1989; Pleasure et al., 1989) , suggesting that NFM protein is the archetype NF protein of the CNS. Second, during development of the CNS, NFM coexpresses with NFL Tohyama et al., 1991) or appears somewhat earlier than NFL (Tapscott et al., 1981; Bennett and Dilullo, 1985; Szaro et al., 1989; Yachnis et al., 1993) . Thus, this temporal relationship places NFM in a critical position to regulate the synthesis of the other two NF subunits.
Multileveled regulatory mechanisms have been proposed to control the synthesis of the NFL subunit (Lindenbaum et al., 1988; Ikenaka et al., 1990; Monteiro et al., 1990; Nakahira et al., 1990; Beaudet et al., 1993a,b; Shneidman et al., 1993) . Our RNase protection assays revealed no significant increase in mNFL m R N A in either of these two lines of transgenic mice, suggesting that the increased levels of mNFL protein are due to posttranscriptional regulatory mechanisms. Although the nature of these mechanisms is unclear at this time, there are several plausible considerations. For example, since NFM proteins bind with high affinity to single-stranded RNA and D N A in vitro (Traub et al., 1985) , it is possible that such interactions are involved in regulating NF protein levels in vivo. Alternatively, the assembly of IF proteins into filaments may increase the levels of an IF subunit in transfected cells by retarding the degradation of the artificially expressed protein (Giudice and Fuchs, 1987; Knapp and Franke, 1989; Kulesh et al., 1989) . Thus, the overexpression of NFM protein could increase the levels of mNFL protein by copolymerizing with and stabilizing all available mNFL. In this regard, it is interesting that the expression of K14 cytokeratin without its partner K6b in transfected 3T3 fibroblasts led to the formation of aggregates of K14, while no aggregates formed when both K14 and K6b were coexpressed in transfected cells, where they formed a network (Giudice and Fuchs, 1987) . This finding may ex-plain why no NF inclusions are found in the NFMBammice for up to I yr (data not shown).
Notably, mNFH protein was less extensively phosphorylated in both lines of transgenic mice described here. Although the decrease in the highly phosphorylated NFHP 3+ isoform in the NFMBam-mice might be intepreted to reflect a decrease in total mNFH protein, the appearance of a poorly phosphorylated mNFHP-isoform in the NFM37 mice clearly demonstrates that the extent of phosphorylation of mNFH indeed decreases in these transgenic mice. Furthermore, the larger decrease in the phosphorylation state of mNFH in the NFM37 mice, compared with the NFMBam-mice may be ascribed to the presence of MPR in the hNFM, which is fully phosphorylated in the NFM37 mice. Thus, we infer that the phosphorylation state of mNFH protein is regulated by the amount and phosphorylation state of hNFM proteins.
Electron microscopy showed that the axons of NFMBammice had more NFs packed at a higher density than control mice. Because the packing density of myelinated axons is determined by both the number of NFs and the phosphorylation state of these NFs (Monteiro et al., 1990; de Waegh et al., 1992; Gotow et al., 1994; Nixon et al., 1994) , our data suggest that hippocampal neurons of the NFMBam-mice compensate for the increased number of NFs by reducing the extent to which the mNFH is phosphorylated. This in turn allows NFs to pack at higher densities without increasing the caliber of axons. The more obvious reduction of mNFH phosphorylation state in NFM37 mice compared with the NFMBam-mice further substantiates the view that both NFM and NFH proteins contribute to regulating the NF packing density and that their phosphorylation state is regulated in a coordinate manner. With more potential phosphorylation sites in its tail domain, the NFH protein may be a better interfilamentous spacer than NFM. The neocortical and hippocampal neurons in transgenic mice may prefer NFM as the spacer rather than NFH because their myelinated axons are small. That the extent of phosphorylation of mNFH protein in spinal cord remains unchanged in transgenic mice may reflect the different capacities of the myelinated axons in brain or spinal cord to accommodate NF sidearms. Accordingly, the myelinated axons in the spinal cord are much larger in diameter than those in the brain. The random distribution pattern of interneurofilamentous spaces (Price et al., 1988) suggests that the myelinated axons in the spinal cord could accommodate variable number of NFs. Thus, the increase in NFM and NFL proteins may have less of an impact on spinal cord versus brain axons. Accordingly, this increase does not change the extent of phosphorylation of mNFH in the spinal cord. This interpretation is supported by the electron microscopy studies of the sciatic nerves of NFM37 and control mice, which did not reveal any significant change in the packing density of NFs or the diameter of these axons in the NFM37 mice (data not shown).
While these and several of the other issues discussed earlier concerning the mechanisms that regulate the metabolism and function of NFs remain to be specified in detail, the studies of transgenic mice described here suggest that NFM might play a dominant role in the in vivo regulation of NFL expression, the stoichiometry of NF subunits, and the phosphorylation state of NFH in the brain. Further, our studies imply that the phosphorylation state of both NFM and NFH proteins plays a role in regulating the packing density of NFs in CNS axons. Additional insights into the validity of these inferences should help clarify how alterations in the metabolism of NF proteins contribute to the pathogenesis of human neurodegenerative diseases characterized by a disruption of the neuronal cytoskeleton.
